Miller; Neil Derek
Patent Applications and Registrations
Patent applications and USPTO patent grants for Miller; Neil Derek.The latest application filed is for "substituted diketopiperazines as oxytocin antagonists".
- Miller; Neil Derek - Harlow GB
- Miller; Neil Derek - Stevenage GB
- Miller; Neil Derek - Singapore SG
- Miller; Neil Derek - Essex GB
- Miller; Neil Derek - Hertfordshire GB
- Miller, Neil Derek - Harlow Essex GB
| Patent | Date |
|---|---|
| Substituted diketopiperazines as oxytocin antagonists Grant 8,541,579 - Borthwick , et al. September 24, 2 | 2013-09-24 |
| Substituted Diketopiperazines As Oxytocin Antagonists App 20130131338 - Borthwick; Alan David ; et al. | 2013-05-23 |
| Substituted diketopiperazines as oxytocin antagonists Grant 8,367,673 - Borthwick , et al. February 5, 2 | 2013-02-05 |
| Naphthalene derivatives Grant 7,732,622 - Congreve , et al. June 8, 2 | 2010-06-08 |
| Benzoisoindole derivatives and their use as EP4 receptor ligands Grant 7,718,689 - Healy , et al. May 18, 2 | 2010-05-18 |
| Substituted Diketopiperazines As Oxytocin Antagonists App 20090186867 - Borthwick; Alan David ; et al. | 2009-07-23 |
| Substituted diketopiperazines as oxytocin antagonists Grant 7,514,437 - Borthwick , et al. April 7, 2 | 2009-04-07 |
| Benzoisoindole Derivatives And Their Use As EP4 Receptor Ligands App 20090030061 - Healy; Mark Patrick ; et al. | 2009-01-29 |
| Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor App 20090012056 - Ahmed; Mahmood ; et al. | 2009-01-08 |
| 5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders App 20080318933 - Ahmed; Mahmood ; et al. | 2008-12-25 |
| Heterocyclyl Compounds App 20080275053 - Giblin; Gerard Martin Paul ; et al. | 2008-11-06 |
| Phenyl compounds Grant 7,446,222 - Bit , et al. November 4, 2 | 2008-11-04 |
| Naphthalene Derivatives App 20080234358 - Congreve; Miles Stuart ; et al. | 2008-09-25 |
| Novel Compounds App 20070232657 - Ahmed; Mahmood ; et al. | 2007-10-04 |
| Phenyl Compounds And Their Use In The Treatment Of Conditions Mediated By The Action Of Pge2 At The Ep1 Receptor App 20070225340 - Bit; Rino Antonio ; et al. | 2007-09-27 |
| 3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders App 20070191345 - Ahmed; Mahmood ; et al. | 2007-08-16 |
| Benzo[F]Isoindole Derivatives With Affinity To The EP4 Receptor App 20070088068 - Congreve; Miles Stuart ; et al. | 2007-04-19 |
| Pyrrole compounds for the treatment of prostaglandine mediated diseases App 20070082912 - Giblin; Gerard Martin Paul ; et al. | 2007-04-12 |
| Pyrrole compounds App 20070072906 - Giblin; Gerard Martin Paul ; et al. | 2007-03-29 |
| Phenyl compounds App 20060235057 - Bit; Rino Antonio ; et al. | 2006-10-19 |
| Naphathalene derivatives which bind to the EP4 receptor Grant 6,924,297 - Giblin , et al. August 2, 2 | 2005-08-02 |
| Substituted diketopiperazines as oxytocin antagonists App 20050148572 - Borthwick, Alan David ; et al. | 2005-07-07 |
| Benzo'fisoindole derivatives with affinity to the ep4 receptor App 20050080257 - Congreve, Miles Stuart ; et al. | 2005-04-14 |
| Naphathalene derivatives which bind to the ep4 receptor App 20040102508 - Giblin, Gerard Martin Paul ; et al. | 2004-05-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 